Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 480

1.

Missed Fog?: On the Potential of Obtaining Observations at Increased Resolution During Shallow Fog Events.

Izett JG, Schilperoort B, Coenders-Gerrits M, Baas P, Bosveld FC, van de Wiel BJH.

Boundary Layer Meteorol. 2019;173(2):289-309. doi: 10.1007/s10546-019-00462-3. Epub 2019 Jul 10.

2.

Dutch fog: On the observed spatio-temporal variability of fog in the Netherlands.

Izett JG, van de Wiel BJH, Baas P, van Hooft JA, Schulte RB.

Q J R Meteorol Soc. 2019 Jul;145(723):2817-2834. doi: 10.1002/qj.3597. Epub 2019 Aug 2.

3.

Pembrolizumab monotherapy for PD-L1 ≥50% non-small cell lung cancer, undisputed first choice?

Theelen WSME, Baas P.

Ann Transl Med. 2019 Jul;7(Suppl 3):S140. doi: 10.21037/atm.2019.06.35. No abstract available.

4.

EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.

Nicholson AG, Sauter JL, Nowak AK, Kindler HL, Gill RR, Remy-Jardin M, Armato SG 3rd, Fernandez-Cuesta L, Bueno R, Alcala N, Foll M, Pass H, Attanoos R, Baas P, Beasley MB, Brcic L, Butnor KJ, Chirieac LR, Churg A, Courtiol P, Dacic S, De Perrot M, Frauenfelder T, Gibbs A, Hirsch FR, Hiroshima K, Husain A, Klebe S, Lantuejoul S, Moreira A, Opitz I, Perol M, Roden A, Roggli V, Scherpereel A, Tirode F, Tazelaar H, Travis WD, Tsao MS, van Schil P, Vignaud JM, Weynand B, Cree I, Rusch VW, Girard N, Galateau-Salle F.

J Thorac Oncol. 2019 Sep 20. pii: S1556-0864(19)33232-0. doi: 10.1016/j.jtho.2019.08.2506. [Epub ahead of print]

PMID:
31546041
5.

Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath.

de Vries R, Muller M, van der Noort V, Theelen WSME, Schouten RD, Hummelink K, Muller SH, Wolf-Lansdorf M, Dagelet JWF, Monkhorst K, Maitland-van der Zee AH, Baas P, Sterk PJ, van den Heuvel MM.

Ann Oncol. 2019 Sep 17. pii: mdz279. doi: 10.1093/annonc/mdz279. [Epub ahead of print]

PMID:
31529107
6.

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.

Nosaki K, Saka H, Hosomi Y, Baas P, de Castro G Jr, Reck M, Wu YL, Brahmer JR, Felip E, Sawada T, Noguchi K, Han SR, Piperdi B, Kush DA, Lopes G.

Lung Cancer. 2019 Sep;135:188-195. doi: 10.1016/j.lungcan.2019.07.004. Epub 2019 Jul 8.

PMID:
31446994
7.

I love my dog.

Muller M, Baas P.

Lung Cancer. 2019 Sep;135:228-229. doi: 10.1016/j.lungcan.2019.07.023. Epub 2019 Jul 25. No abstract available.

PMID:
31400821
8.

A multicenter, randomized, phase II/III study of dendritic cells loaded with allogeneic tumor cell lysate (MesoPher) in subjects with mesothelioma as maintenance therapy after chemotherapy: DENdritic cell Immunotherapy for Mesothelioma (DENIM) trial.

Belderbos RA, Baas P, Berardi R, Cornelissen R, Fennell DA, van Meerbeeck JP, Scherpereel A, Vroman H, Aerts JGJV.

Transl Lung Cancer Res. 2019 Jun;8(3):280-285. doi: 10.21037/tlcr.2019.05.05.

9.

Reply to K. Masuda et al.

Fennell DA, Taylor P, Gilligan D, Nakano T, Scherpereel A, Pavlakis N, van Meerbeeck JP, Aerts JGJV, Nowak AK, Kindler H, Baas P.

J Clin Oncol. 2019 Sep 1;37(25):2294-2295. doi: 10.1200/JCO.19.01208. Epub 2019 Jul 22. No abstract available.

PMID:
31329517
10.

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial.

Theelen WSME, Peulen HMU, Lalezari F, van der Noort V, de Vries JF, Aerts JGJV, Dumoulin DW, Bahce I, Niemeijer AN, de Langen AJ, Monkhorst K, Baas P.

JAMA Oncol. 2019 Jul 11. doi: 10.1001/jamaoncol.2019.1478. [Epub ahead of print]

PMID:
31294749
11.

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI.

CA Cancer J Clin. 2019 Sep;69(5):402-429. doi: 10.3322/caac.21572. Epub 2019 Jul 8. Review.

12.

Resection of hepatic and pulmonary metastasis from metastatic esophageal and gastric cancer: a nationwide study.

Seesing MFJ, van der Veen A, Brenkman HJF, Stockmann HBAC, Nieuwenhuijzen GAP, Rosman C, van den Wildenberg FJH, van Berge H, van Duijvendijk P, Wijnhoven BPL, Stoot JHMB, Lacle M, Ruurda JP, van Hillegersberg R, Baas PC, Boerma D, de Steur WO, de Waard JWD, Heisterkamp J, van Hillo M, Kouwenhoven EA, Liem MSL, van der Peet DL, Pierie JPEN, Plukker JTM, Roumen RMH, Tetteroo GWM, van Workum F.

Dis Esophagus. 2019 Apr 25. pii: doz034. doi: 10.1093/dote/doz034. [Epub ahead of print]

PMID:
31220859
13.

Treatment of older patients with immune checkpoint inhibitors in routine clinical care as compared to inclusion in pivotal registration trials.

Crombag MBS, Haanen JBAG, Baas P, Beijnen JH, Huitema ADR.

J Geriatr Oncol. 2019 Jun 14. pii: S1879-4068(19)30118-3. doi: 10.1016/j.jgo.2019.06.001. [Epub ahead of print] No abstract available.

PMID:
31208830
14.

Wild chimpanzees (Pan troglodytes troglodytes) exploit tortoises (Kinixys erosa) via percussive technology.

Pika S, Klein H, Bunel S, Baas P, Théleste E, Deschner T.

Sci Rep. 2019 May 23;9(1):7661. doi: 10.1038/s41598-019-43301-8.

15.

New hypothesis for the etiology of SPAST-based hereditary spastic paraplegia.

Qiang L, Piermarini E, Baas PW.

Cytoskeleton (Hoboken). 2019 Apr;76(4):289-297. doi: 10.1002/cm.21528. Epub 2019 Jul 3.

PMID:
31108029
16.

Confocal Laser Endomicroscopy as a Guidance Tool for Pleural Biopsies in Malignant Pleural Mesothelioma.

Wijmans L, Baas P, Sieburgh TE, de Bruin DM, Ghuijs PM, van de Vijver MJ, Bonta PI, Annema JT.

Chest. 2019 Oct;156(4):754-763. doi: 10.1016/j.chest.2019.04.090. Epub 2019 May 7.

PMID:
31075217
17.

Transitions in the wintertime near-surface temperature inversion at Dome C, Antarctica.

Baas P, van de Wiel BJH, van Meijgaard E, Vignon E, Genthon C, van der Linden SJA, de Roode SR.

Q J R Meteorol Soc. 2019 Apr;145(720):930-946. doi: 10.1002/qj.3450. Epub 2019 Mar 8.

18.

A retrospective cohort study of PD-L1 prevalence, molecular associations and clinical outcomes in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape Project.

Kerr KM, Thunnissen E, Dafni U, Finn SP, Bubendorf L, Soltermann A, Verbeken E, Biernat W, Warth A, Marchetti A, Speel EM, Pokharel S, Quinn AM, Monkhorst K, Navarro A, Madsen LB, Radonic T, Wilson J, De Luca G, Gray SG, Cheney R, Savic S, Martorell M, Muley T, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dziadziuszko R, Vansteenkiste J, Weder W, Polydoropoulou V, Geiger T, Kammler R, Peters S, Stahel R; Lungscape Consortium.

Lung Cancer. 2019 May;131:95-103. doi: 10.1016/j.lungcan.2019.03.012. Epub 2019 Mar 15.

PMID:
31027705
19.

Needle-based confocal laser endomicroscopy for real-time diagnosing and staging of lung cancer.

Wijmans L, Yared J, de Bruin DM, Meijer SL, Baas P, Bonta PI, Annema JT.

Eur Respir J. 2019 Jun 20;53(6). pii: 1801520. doi: 10.1183/13993003.01520-2018. Print 2019 Jun.

PMID:
31023849
20.

Tau: It's Not What You Think.

Baas PW, Qiang L.

Trends Cell Biol. 2019 Jun;29(6):452-461. doi: 10.1016/j.tcb.2019.02.007. Epub 2019 Mar 28. Review.

PMID:
30929793
21.

Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions.

Hummelink K, Muller M, Linders TC, van der Noort V, Nederlof PM, Baas P, Burgers S, Smit EF, Meijer GA, van den Heuvel MM, van den Broek D, Monkhorst K.

ERJ Open Res. 2019 Mar 25;5(1). pii: 00016-2019. doi: 10.1183/23120541.00016-2019. eCollection 2019 Feb.

22.

I-O Optimise: a novel multinational real-world research platform in thoracic malignancies.

Ekman S, Griesinger F, Baas P, Chao D, Chouaid C, O'Donnell JC, Penrod JR, Daumont M, Lacoin L, McKenney A, Khovratovich M, Munro RE, Durand-Zaleski I, Johnsen SP.

Future Oncol. 2019 May;15(14):1551-1563. doi: 10.2217/fon-2019-0025. Epub 2019 Mar 11.

23.

Mitotic Motor KIFC1 Is an Organizer of Microtubules in the Axon.

Muralidharan H, Baas PW.

J Neurosci. 2019 May 15;39(20):3792-3811. doi: 10.1523/JNEUROSCI.3099-18.2019. Epub 2019 Feb 25.

PMID:
30804089
24.

Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study.

Fennell DA, Baas P, Taylor P, Nowak AK, Gilligan D, Nakano T, Pachter JA, Weaver DT, Scherpereel A, Pavlakis N, van Meerbeeck JP, Cedrés S, Nolan L, Kindler H, Aerts JGJV.

J Clin Oncol. 2019 Apr 1;37(10):790-798. doi: 10.1200/JCO.2018.79.0543. Epub 2019 Feb 20.

PMID:
30785827
25.

Reasons for low uptake of a psychological intervention offered to cancer survivors with elevated depressive symptoms.

van der Donk LJ, Tovote KA, Links TP, Roodenburg JLN, Kluin-Nelemans JC, Arts HJG, Mul VEM, van Ginkel RJ, Baas PC, Hoff C, Sanderman R, Fleer J, Schroevers MJ.

Psychooncology. 2019 Apr;28(4):830-838. doi: 10.1002/pon.5029. Epub 2019 Mar 5. Erratum in: Psychooncology. 2019 Sep;28(9):1942.

26.

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial.

Disselhorst MJ, Quispel-Janssen J, Lalezari F, Monkhorst K, de Vries JF, van der Noort V, Harms E, Burgers S, Baas P.

Lancet Respir Med. 2019 Mar;7(3):260-270. doi: 10.1016/S2213-2600(18)30420-X. Epub 2019 Jan 16.

PMID:
30660511
27.

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial.

Herbst RS, Baas P, Perez-Gracia JL, Felip E, Kim DW, Han JY, Molina JR, Kim JH, Dubos Arvis C, Ahn MJ, Majem M, Fidler MJ, Surmont V, de Castro G, Garrido M, Shentu Y, Emancipator K, Samkari A, Jensen EH, Lubiniecki GM, Garon EB.

Ann Oncol. 2019 Feb 1;30(2):281-289. doi: 10.1093/annonc/mdy545.

PMID:
30657853
28.

Knockdown of Fidgetin Improves Regeneration of Injured Axons by a Microtubule-Based Mechanism.

Matamoros AJ, Tom VJ, Wu D, Rao Y, Sharp DJ, Baas PW.

J Neurosci. 2019 Mar 13;39(11):2011-2024. doi: 10.1523/JNEUROSCI.1888-18.2018. Epub 2019 Jan 15.

29.

Hereditary spastic paraplegia: gain-of-function mechanisms revealed by new transgenic mouse.

Qiang L, Piermarini E, Muralidharan H, Yu W, Leo L, Hennessy LE, Fernandes S, Connors T, Yates PL, Swift M, Zholudeva LV, Lane MA, Morfini G, Alexander GM, Heiman-Patterson TD, Baas PW.

Hum Mol Genet. 2019 Apr 1;28(7):1136-1152. doi: 10.1093/hmg/ddy419.

PMID:
30520996
30.

A randomized phase II study of pleurectomy/decortication preceded or followed by (neo-)adjuvant chemotherapy in patients with early stage malignant pleural mesothelioma (EORTC 1205).

Raskin J, Surmont V, Cornelissen R, Baas P, van Schil PEY, van Meerbeeck JP.

Transl Lung Cancer Res. 2018 Oct;7(5):593-598. doi: 10.21037/tlcr.2018.05.07. Review.

31.

Current chemotherapy strategies in malignant pleural mesothelioma.

de Gooijer CJ, Baas P, Burgers JA.

Transl Lung Cancer Res. 2018 Oct;7(5):574-583. doi: 10.21037/tlcr.2018.04.10. Review.

32.

Understanding and Reducing False Alarms in Observational Fog Prediction.

Izett JG, van de Wiel BJH, Baas P, Bosveld FC.

Boundary Layer Meteorol. 2018;169(2):347-372. doi: 10.1007/s10546-018-0374-2. Epub 2018 Jul 3.

33.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-mediated kif15 mutations accelerate axonal outgrowth during neuronal development and regeneration in zebrafish.

Dong Z, Wu S, Zhu C, Wang X, Li Y, Chen X, Liu D, Qiang L, Baas PW, Liu M.

Traffic. 2019 Jan;20(1):71-81. doi: 10.1111/tra.12621. Epub 2018 Nov 29.

34.

Treat it or Leave it: Immuno-Oncology in Mesothelioma Observed by the Eyes of Argus.

de Gooijer CJ, Baas P.

J Thorac Oncol. 2018 Nov;13(11):1619-1622. doi: 10.1016/j.jtho.2018.08.2024. No abstract available. Erratum in: J Thorac Oncol. 2019 Feb;14(2):314.

PMID:
30368407
35.

Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review.

Zazuli Z, Vijverberg S, Slob E, Liu G, Carleton B, Veltman J, Baas P, Masereeuw R, Maitland-van der Zee AH.

Front Pharmacol. 2018 Sep 27;9:1111. doi: 10.3389/fphar.2018.01111. eCollection 2018.

36.

Diagnostic validation and interpretation of longitudinal circulating biomarkers using a biomarker response characteristic plot.

Moritz R, Muller M, Korse CM, van den Broek D, Baas P, van den Noort V, Ten Hoeve JJ, van den Heuvel MM, van Rossum HH.

Clin Chim Acta. 2018 Dec;487:6-14. doi: 10.1016/j.cca.2018.09.015. Epub 2018 Sep 8.

PMID:
30201371
37.

Tau Does Not Stabilize Axonal Microtubules but Rather Enables Them to Have Long Labile Domains.

Qiang L, Sun X, Austin TO, Muralidharan H, Jean DC, Liu M, Yu W, Baas PW.

Curr Biol. 2018 Jul 9;28(13):2181-2189.e4. doi: 10.1016/j.cub.2018.05.045. Epub 2018 Jun 28.

38.

Controlled before-after intervention study of suburb-wide street changes to increase walking and cycling: Te Ara Mua-Future Streets study design.

Macmillan AK, Mackie H, Hosking JE, Witten K, Smith M, Field A, Woodward A, Hoskins R, Stewart J, van der Werf B, Baas P.

BMC Public Health. 2018 Jul 9;18(1):850. doi: 10.1186/s12889-018-5758-1.

39.

Trophoblast Glycoprotein is Associated With a Favorable Outcome for Mesothelioma and a Target for Antibody Drug Conjugates.

Schunselaar LM, Monkhorst K, van der Noort V, Wijdeven R, Peters D, Zwart W, Neefjes J, Baas P.

J Thorac Oncol. 2018 Oct;13(10):1577-1587. doi: 10.1016/j.jtho.2018.06.008. Epub 2018 Jun 27.

40.

30 Immunotherapy in advanced NSCLC-from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT).

de Marinis F, Ciardiello F, Baas P, Crinò L, Giaccone G, Grossi F, Hellmann MD, Mok TSK, Lena H, Paz-Ares L, Rodriguez-Abreu D, Von Pavel J, Gridelli C.

ESMO Open. 2018 May 31;3(4):e000298. doi: 10.1136/esmoopen-2017-000298. eCollection 2018. Review.

41.

Malignant pleural effusions: will PROMISE make its name true?

Baas P, Burgers S.

Lancet Oncol. 2018 Jul;19(7):853-855. doi: 10.1016/S1470-2045(18)30361-9. Epub 2018 Jun 13. No abstract available.

PMID:
29908988
42.

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma.

Quispel-Janssen J, van der Noort V, de Vries JF, Zimmerman M, Lalezari F, Thunnissen E, Monkhorst K, Schouten R, Schunselaar L, Disselhorst M, Klomp H, Hartemink K, Burgers S, Buikhuisen W, Baas P.

J Thorac Oncol. 2018 Oct;13(10):1569-1576. doi: 10.1016/j.jtho.2018.05.038. Epub 2018 Jun 14.

43.

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.

Rolfo C, Mack PC, Scagliotti GV, Baas P, Barlesi F, Bivona TG, Herbst RS, Mok TS, Peled N, Pirker R, Raez LE, Reck M, Riess JW, Sequist LV, Shepherd FA, Sholl LM, Tan DSW, Wakelee HA, Wistuba II, Wynes MW, Carbone DP, Hirsch FR, Gandara DR.

J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6. Review.

44.

Immuno-oncology in malignant pleural mesothelioma.

Baas P, Disselhorst M.

Lancet Respir Med. 2018 Jun;6(6):408-410. doi: 10.1016/S2213-2600(18)30176-0. Epub 2018 May 15. No abstract available.

PMID:
29773327
45.

Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.

Gridelli C, Baas P, Barlesi F, Ciardiello F, Crinò L, Felip E, Gadgeel S, Papadimitrakopoulou V, Paz-Ares L, Planchard D, Perol M, Hanna N, Sgambato A, Casaluce F, de Marinis F.

Clin Lung Cancer. 2018 Jul;19(4):301-314. doi: 10.1016/j.cllc.2017.12.010. Epub 2017 Dec 22. Review.

PMID:
29396237
46.

From Near-Neutral to Strongly Stratified: Adequately Modelling the Clear-Sky Nocturnal Boundary Layer at Cabauw.

Baas P, van de Wiel BJH, van der Linden SJA, Bosveld FC.

Boundary Layer Meteorol. 2018;166(2):217-238. doi: 10.1007/s10546-017-0304-8. Epub 2017 Oct 7.

47.

Population-level assessment of genetic diversity and habitat fragmentation in critically endangered Grauer's gorillas.

Baas P, van der Valk T, Vigilant L, Ngobobo U, Binyinyi E, Nishuli R, Caillaud D, Guschanski K.

Am J Phys Anthropol. 2018 Mar;165(3):565-575. doi: 10.1002/ajpa.23393. Epub 2018 Jan 4.

PMID:
29313894
48.

Polarity Sorting of Microtubules in the Axon.

Rao AN, Baas PW.

Trends Neurosci. 2018 Feb;41(2):77-88. doi: 10.1016/j.tins.2017.11.002. Epub 2017 Nov 30. Review.

49.

Evaluation of NGS and RT-PCR Methods for ALK Rearrangement in European NSCLC Patients: Results from the European Thoracic Oncology Platform Lungscape Project.

Letovanec I, Finn S, Zygoura P, Smyth P, Soltermann A, Bubendorf L, Speel EJ, Marchetti A, Nonaka D, Monkhorst K, Hager H, Martorell M, Sejda A, Cheney R, Hernandez-Losa J, Verbeken E, Weder W, Savic S, Di Lorito A, Navarro A, Felip E, Warth A, Baas P, Meldgaard P, Blackhall F, Dingemans AM, Dienemann H, Dziadziuszko R, Vansteenkiste J, O'Brien C, Geiger T, Sherlock J, Schageman J, Dafni U, Kammler R, Kerr K, Thunnissen E, Stahel R, Peters S; European Thoracic Oncology Platform Lungscape Consortium.

J Thorac Oncol. 2018 Mar;13(3):413-425. doi: 10.1016/j.jtho.2017.11.117. Epub 2017 Nov 27.

50.

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project.

Kerr KM, Dafni U, Schulze K, Thunnissen E, Bubendorf L, Hager H, Finn S, Biernat W, Vliegen L, Losa JH, Marchetti A, Cheney R, Warth A, Speel EJ, Blackhall F, Monkhorst K, Jantus Lewintre E, Tischler V, Clark C, Bertran-Alamillo J, Meldgaard P, Gately K, Wrona A, Vandenberghe P, Felip E, De Luca G, Savic S, Muley T, Smit EF, Dingemans AC, Priest L, Baas P, Camps C, Weder W, Polydoropoulou V, Geiger TR, Kammler R, Sumiyoshi T, Molina MA, Shames DS, Stahel RA, Peters S; ETOP Lungscape Consortium.

Ann Oncol. 2018 Jan 1;29(1):200-208. doi: 10.1093/annonc/mdx629.

PMID:
29186353

Supplemental Content

Support Center